Entag, Baby Boy .
HRN: 25-63-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2024
CEFUROXIME 750MG (VIAL)
08/07/2024
08/14/2024
IVT
270 MG
Q8H
SCALD BURN
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes